Shoshana Golden’s Insights

108 total results. Page 1 of 9.

Alerts
RUO-ined: Five Peptide Vendors Learn That ‘Research Use Only’ Is Not a Legal Strategy
Alerts
There Goes the Sun(screen): FDA Removes PABA and Trolamine Salicylate From OTC Monograph
Alerts
Read My Lipstick: FDA Will Not Certify Cosmetic Facility Registration or Product Listing
Investigations Blog
NYSBA Issues Ethics Opinion on Lawyer Involvement in Deceptive Investigative Conduct in FCA Cases
Longevity Lens
Altered States, Standard Rules: FDA Finalizes Guidance on Psychedelic Drug Clinical Trials
Investigations Blog
DOJ Declines to Prosecute Eye Care Management Company Under New Corporate Enforcement Policy; Founder Indicted for Fraud and Kickbacks
Alerts
The (Pep)Tides Turn: FDA Panel Recommends Six of Seven for Compounding
Alerts
Reinventing the Wheel: FDA’s Hub-and-Spoke Fix for Drug Manufacturing Registration
Alerts
2027 Physician Fee Schedule Proposed Rule: CMS Proposes Mandatory 340B Claims Data Reporting
Alerts
50 Shades of Legally Gray: FDA’s Juicy Peptide Cliffhanger
Alerts
CMS Issues 2027 Hospital Outpatient Prospective Payment System Proposed Rule: Key Takeaways for Pharma
Alerts
Here Comes the Sun(screen): FDA Greenlights Bemotrizinol as Active Ingredient